Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Clinical trial NCT06344130 · RECRUITING

Trial details

NCT number: NCT06344130
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Astrocytoma Glioma Recurrent Glioblastoma

Start date: 2024-10-01
Primary completion: 2027-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.